<DOC>
	<DOCNO>NCT02831192</DOCNO>
	<brief_summary>The purpose study see whether HLA-mismatched donor cell infusion chemotherapy ( microtransplantation，MST ) could increase complete remission ( CR ) improve survival old patient acute myeloid leukemia ( AML ) ，the investigator conduct prospective , multicenter clinical trial HLA-mismatched MST estimate outcome toxicity .</brief_summary>
	<brief_title>Microtransplantation Older Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>de novo acute myeloid leukemia age 6090 HLA mismatch donor suitable donor donor refuse patient refuse accept donor cell</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>